Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation - Surgalign

The machine learning system is part of HOLO AITM, Surgalign's core technology in artificial intelligence and augmented reality. DEERFIELD, Ill., Aug. 19, 2021 – Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the United States Patent and Trademark Office (USPTO) recently issued a patent covering a machine learning system for automated segmentation of a three-dimensional bony structure in a medical image. The granted patent expands and further strengthens the company's HOLO AI technology portfolio. "This patent is a foundational element of how we harness technology and data to power our digital surgery platform," said Terry Rich, Surgalign's president and chief executive officer. "While'artificial intelligence' and'machine learning' have become buzzwords that are often misused, misrepresented, and misunderstood, at Surgalign AI is a core competency and a key element of our efficient and highly valuable approach to improving patient's lives."